Curcumin loaded mixed micelles composed of Pluronic P123 and F68: Preparation, optimization and in vitro characterization

Colloids and Surfaces B: Biointerfaces

Volumn 97, Issue , 2012, Pages 101-108

  Zhao, Liyan ^a   Du, Jianchao ^a   Duan, Yuwei ^a   Zang, Ya'ni ^a   Zhang, Huaisong ^a   Yang, Chunfen ^a   Cao, Fengliang ^a   Zhai, Guangxi ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Curcumin; Cytotoxicity; F68; Pluronic P123; Polymeric micelle

Indexed keywords

AVERAGE SIZE; CENTRAL COMPOSITE DESIGNS; CURCUMIN; F68; HYDRATION METHOD; IN-VITRO; MCF-7 CELLS; MIXED MICELLES; NANOCARRIERS; PLURONIC-F68; PLURONICS; POLYMERIC MICELLE; PREPARATION PROCESS; PROPYLENE GLYCOLS; SUSTAINED-RELEASE;

BIOACTIVITY; CYTOTOXICITY; LOADING; OPTIMIZATION; PHARMACODYNAMICS;

MICELLES;

CURCUMIN; NANOCARRIER; POLOXAMER; POLOXAMER F68; POLOXAMER P123; PROPYLENE GLYCOL; UNCLASSIFIED DRUG;

ARTICLE; CELL ENCAPSULATION; CELL SIZE; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG MECHANISM; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; FILM; HYDRATION; IC 50; IN VITRO STUDY; MICELLE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SUSTAINED DRUG RELEASE; ZETA POTENTIAL;

CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; HUMANS; MICELLES; POLOXALENE; POLOXAMER;

EID: 84860994551     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.04.017     Document Type: Article

References (48)

1. Tsai Y.M., Jan W.C., Chien C.F., Lee W.C., Lin L.C., Tsai T.H. Optimised nano-formulation on the bioavailability of hydrophobic polyphenol, curcumin, in freely-moving rats. Food Chem. 2011, 3:918-925.
2. Shishodia S., Sethi G., Aggarwal B.B. Curcumin: getting back to the roots. Ann. N. Y. Acad. Sci. 2005, 1056:206-217.
3. Yallapu M.M., Jaggi M., Chauhan S.C. β-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloid Surf. B: Biointerfaces 2010, 79:113-125.
4. Bar-Sela G., Epelbaum R., Schaffer M. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. Curr. Med. Chem. 2010, 17:190-197.
5. Jurenka J.S. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern. Med. Rev. 2009, 14:141-153.
6. Strimpakos A.S., Sharma R.A. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid. Redox Signal. 2008, 10:511-545.
7. Sharma R.A., Steward W.P., Gescher A.J. Pharmacokinetics and pharmaco-dynamics of curcumin. Adv. Exp. Med. Biol. 2007, 595:453-470.
8. Karewicz A., Bielska D., Gzyl-Malcher B., Kepczynski M., Lach R., Nowakowska M. Interaction of curcumin with lipid monolayers and liposomal bilayers. Colloid Surf. B: Biointerfaces 2011, 88:231-239.
9. Cui J., Yu B., Zhao Y., Zhu W., Li H.L., Zhai G. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int. J. Pharm. 2009, 371:148-155.
10. Sun M., Gao Y., Pei Y., Guo C.Y., Li H., Cao F., Yu A., Zhai G.X. Development of nanosuspension formulation for oral delivery of quercetin. J. Biomed. Nanotechnol. 2010, 6:325.
11. Yallapu M.M., Gupta B.K., Jaggi M., Chauhan S.C. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J. Colloid Interface Sci. 2010, 351:19-29.
12. Suwannateep N., Banlunara W., Wanichwecharungruang S.P., Chiablaem K., Lirdprapamongkol K., Svasti J. Mucoadhesive curcumin nanospheres: biological activity, adhesion to stomach mucosa and release of curcumin into the circulation. J. Control. Release 2011, 151:176-182.
13. Rejinold N.S., Muthunarayanan M., Divyarani V.V., Sreerekha P.R., Chennazhi K.P., Nair S.V., Tamura H., Jayakumar R. Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery. J. Colloid Interface Sci. 2011, 360:39-51.
14. Chiappetta D.A., Sosnik A. Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs. Eur. J. Pharm. Biopharm. 2007, 66:303-317.
15. ® micelles for solubilization of sirolimus and release from the drug eluting stents. Colloid Surf. B: Biointerfaces 2012, 93:180-187.
16. Nakanishi T., Fukushima S., Okamoto K., Suzuki M., Matsumura Y., Yokoyama M., Okano T., Sakurai Y., Kataoka K. Development of the polymer micelle carrier system for doxorubicin. J. Control. Release 2001, 74:295-302.
17. ® micelles. Colloid Surf. B: Biointerfaces 2011, 86:319-326.
18. Zhao Y.Z., Sun C.Z., Lu C.T., Dai D.D., Lv H.F., Wu Y., Wan C.W., Chen L.J., Lin M., Li X.K. Characterization and anti-tumor activity of chemical conjugation of doxorubicin in polymeric micelles (DOX-P) in vitro. Cancer Lett. 2011, 311:187-194.
19. Mizumur Y., Matsumur Y., Yokoyam M., Okano T., Kawaguchi T., Moriyasu F., Kakizoe T. Incorporation of the anticancer agent KRN5500 into polymeric micelles diminishes the pulmonary toxicity. Jpn. J. Cancer Res. 2002, 93:1237-1243.
20. Matsumura Y., Hamaguchi T., Ura T., Muro K., Yamada Y., Shimada Y., Shirao K., Okusaka T., Ueno H., Ikeda M., Watanabe N., Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin Br. J. Cancer 2004, 91:1775-1781.
21. Gao Y., Li L.B., Zhai G. Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin. Colloid Surf. B: Biointerfaces 2008, 64:194-199.
22. Gao Z.G., Fain H.D., Rapoport N. Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. J. Control. Release 2005, 102:203-222.
23. Kulthe S.S., Inamdar N.N., Choudhari Y.M., Shirolikar S.M., Borde L.C., Mourya V.K. Mixed micelle formation with hydrophobic and hydrophilic Pluronic block copolymers: implications for controlled and targeted drug delivery. Colloid Surf. B: Biointerfaces 2011, 88:691-696.
24. Danson S., Ferry D., Alakhov V., Margison J., Kerr D., Jowle D., Brampton M., Halbert G., Ranson M. Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer. Br. J. Cancer 2004, 90:2085-2091.
25. Batrakova E.V., Kabanov A.V. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J. Control. Release 2008, 130:98-106.
26. Jansson J., Schille K., Olofsson G., Cardoso R., Loh W. The interaction between PEO-PPO-PEO triblock copolymers and ionic surfactants in aqueous solution studied using light scattering and calorimetry. J. Phys. Chem. B 2004, 108:82-92.
27. Kabanov A.V., Batrakova E.V., Miller D.W. Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier. Adv. Drug Deliv. Rev. 2003, 55:151-164.
28. Han L.M., Guo J., Zhang L.J., Wang Q.S., Fang X.L. Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel. Acta Pharmacol. Sin. 2006, 27:747-753.
29. Wang Y.Z., Li Y.J., Zhang L.J., Fang X.L. Pharmacokinetics and biodistribution of paclitaxel-loaded Pluronic P105 polymeric micelles. Arch. Pharm. Res. 2008, 31:530-538.
30. Bakshi M.S., Sachar S. Influence of temperature on the mixed micelles of Pluronic F127 and P103 with dimethylene-bis-(dodecyldimethylammonium bromide). J. Colloid Interface Sci. 2006, 296:309-315.
31. Zhou Q., Zhang Z., Chen T., Guo X., Zhou S. Preparation and characterization of thermosensitive pluronic F127-b-poly(e{open}-caprolactone) mixed micelles. Colloid Surf. B: Biointerfaces 2011, 86:45-57.
32. Kim S.Y., Ha J.C., Lee Y.M. Poly(ethylene oxide)-poly(propylene oxide)-poly (ethylene oxide)/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymeric nanospheres. II. Thermo-responsive drug release behaviors. J. Control. Release 2000, 65:345-358.
33. Wulff-Pérez M., Torcello-Gómez A., Gálvez-Ruíz M.J., Martín-Rodríguez A. Stability of emulsions for parenteral feeding: preparation and characterization of o/w nanoemulsions with natural oils and Pluronic f68 as surfactant. Food Hydrocolloids 2009, 4:1096-1102.
34. Cha M.H., Choi J., Choi B.G., Park K., Kim I.H., Jeong B., Han D.K. Synthesis and characterization of novel thermo-responsive F68 block copolymers with cell-adhesive RGD peptide. J. Colloid Interface Sci. 2011, 360:78-85.
35. Dabholkar R.D., Sawant R.M., Mongayt D.A., Devarajan P.V., Torchilin V.P. Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. Int. J. Pharm. 2006, 315:148-157.
36. Wei Z., Hao J., Yuan S., Li Y., Juan W., Sha X., Fang X. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int. J. Pharm. 2009, 376:176-185.
37. Rodrigues L., Teixeira J., Oliveira R., van der Mei H.C. Response surface optimization of the medium components for the production of biosurfactants by probiotic bacteria. Process Biochem. 2006, 41:1-10.
38. Arockiasamy S., Banik R.M. Optimization of gellan gum production by Sphingomonas paucimobilis ATCC 31461 with nonionic surfactants using central composite design. J. Biosci. Bioeng. 2008, 105:204-210.
39. Dalcin M.G., Pirete M.M., Lemos D.A., Ribeiro E.J., Cardoso V.L., de Resende M.M. Evaluation of hexavalent chromium removal in a continuous biological filter with the use of central composite design (CCD). J. Environ. Manage. 2011, 92:1165-1173.
40. Bae K.H., Choi S.H., Park S.Y., Lee Y., Park T.G. Thermosensitive pluronic micelles stabilized by shell cross-linking with gold nanoparticles. Langmuir 2006, 22:6380-6384.
41. Gong J., Huo M., Zhou J., Zhang Y., Peng X., Yu D., Zhang H., Li J. Synthesis, characterization, drug-loading capacity and safety of novel octyl modified serum albumin micelles. Int. J. Pharm. 2009, 376:161-168.
42. Araújo J., Gonzalez-Mira E., Egea M.A., Garcia M.L., Souto E.B. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications. Int. J. Pharm. 2010, 393:167-175.
43. Sezgin Z., Yuksel N., Baykara T. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur. J. Pharm. Biopharm. 2006, 64:261-268.
44. Prabaharan M., Grailer J.J., Pilla S., Steeber D.A., Gong S. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery. Biomaterials 2009, 30:5757-5766.
45. Müh F., Zouni A. Micelle formation in the presence of photosystem I. Biochim. Biophys. Acta 2008, 1778:2298-2307.
46. Zhao L., Shi Y., Zou S., Sun M., Li L., Zhai G. Formulation and in vitro evaluation of quercetin loaded polymeric micelles composed of Pluronic P123 and d-a-tocopheryl polyethylene glycol succinate. J. Biomed. Nanotechnol. 2011, 7:358-365.
47. Kim K.S., Park S.J. Effect of porous silica on sustained release behaviors of pH sensitive Pluronic F127/poly(acrylic acid) hydrogels containing tulobutero. Colloid Surf. B: Biointerfaces 2010, 80:240-246.
48. Thomas H., Coley H.M. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein. Cancer Control 2003, 10:159-165.